The global Parenteral Nutrition market size is projected to reach US$ 270.9 million by 2027, from US$ 204.9 million in 2020, at a CAGR of 4.0% during 2021-2027. The presence of a large number of malnourished children, increasing premature births, and rising occurrence of cancer is expected to drive the Parenteral Nutrition market
Parenteral nutrition (PN) is the feeding of nutritional products to a person intravenously, bypassing the usual process of eating and digestion. The person receives nutritional formulae that contain nutrients such as glucose, salts, amino acids, lipids and added vitamins and dietary minerals.
The single-dose amino acid solutions segment is expected to be the most lucrative during the forecast period. This is attributable to an increase in the number of health-conscious people and the global incidence of numerous chronic diseases. During the projection period, revenue CAGR for the lipid emulsion segment is expected to be strong.
North America is expected to be the most lucrative segment. This is due to the rise in awareness about parenteral nutrition as well as, growing incidence of chronic diseases coupled with rising healthcare expenses in the region.
The global Parenteral Nutrition market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parenteral Nutrition market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
|
Report Metric |
Details |
|
Report Name |
Parenteral Nutrition Market |
|
The market size in 2020 |
USD 204.9 Million |
|
The revenue forecast in 2027 |
USD 270.9 Million |
|
Growth Rate |
CAGR of 4.0% from 2021 to 2027 |
|
Base year considered |
2019 |
|
Market size available for years |
2021-2027 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Type, End-User, Offerings, and Region |
|
Report coverage |
Revenue & volume forecast, company share, competitive landscape, growth factors, and trends |
|
Geographic regions covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Ans. The global parenteral nutrition market size is projected to reach US$ 270.9 million by 2027, from US$ 204.9 million in 2020, at a CAGR of 4.0% during 2021-2027.
Ans. North America is expected to be the most lucrative segment. This is due to the rise in awareness about parenteral nutrition as well as, growing incidence of chronic diseases coupled with rising healthcare expenses in the region.
Ans. The single-dose amino acid solutions segment is expected to be the most lucrative during the forecast period.
Ans. The forecast period for the parenteral nutrition market is 2021 to 2027
Ans. The major vendors operating in the parenteral nutrition market include Laboratorios Vijosa, Eurofarma, Corporacion De Laboratorios Farmaceuticos, Laboratorios Pharmakon, S.A., Laboratorio Industrial Centroamericano S.A., Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay
Ans. The increasing geriatric population is expected to further augment the parenteral nutrition market. The geriatric population is more prone to serious hospitalization that needs administration of parenteral nutrition.
$3350
$6700
